Comparison of the health related quality of life at baseline and after each intradetrusor injections of botulinum toxin in patients with NDO
Injections, number |
1 |
2 |
3 |
4 |
5 |
Patients, number |
52 |
47 |
34 |
16 |
5 |
female |
8 |
3 |
1 |
1 |
0 |
male |
44 |
43 |
33 |
15 |
5 |
I-QoL |
|
|
|
|
|
Base line |
34.31 ± 6.88 |
38.83 ± 5.41 |
39.14 ± 4.54 |
41.00 ± 4.02 |
34.66 ± 4.06 |
After 12 week |
59.35 ± 7.35 |
65.14 ± 7.74 |
66.65 ± 7.53 |
70.15 ± 8.82 |
68.24 ± 9.93 |
P value |
< 0.001 |
< 0.001 |
< 0.001 |
< 0.001 |
< 0.001 |
IIQ-7 |
|
|
|
|
|
Base line |
14.02 ± 2.24 |
12.38 ± 1.60 |
11.53 ± 1.40 |
11.88 ± 1.36 |
11.60 ± 1.82 |
After 12 week |
11.79 ± 2.11 |
9.70 ± 2.20 |
10.15 ± 2.20 |
10.31 ± 1.45 |
8.60 ± 1.14 |
P value |
< 0.001 |
< 0.001 |
< 0.001 |
< 0.001 |
< 0.001 |
UDI-6 |
|
|
|
|
|
Base line |
13.00 ± 2.12 |
11.74 ± 1.33 |
11.00 ± 1.23 |
11.50 ± 1.55 |
11.00 ± 1.58 |
After 12 week |
8.15 ± 1.69 |
6.98 ± 1.36 |
6.88 ± 1.94 |
5.94 ± 1.34 |
6.60 ± 1.67 |
P value |
< 0.001 |
< 0.001 |
< 0.001 |
< 0.001 |
< 0.001 |